← Evidence map

ArticleClinical neuroradiology2026

RCBVmax from DSC Perfusion MRI as a Supportive Imaging Biomarker for Differentiating IDH-Mutant Astrocytomas and Oligodendroglioma.

Manoj Mannil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

RCBVmax from DSC Perfusion MRI as a Supportive Imaging Biomarker for Differentiating IDH-Mutant Astrocytomas and Oligodendroglioma. | OpenQuestion